Osimertinib
From Proteopedia
| ||||||||||||
Osimertinib, sold under the brand name Tagrisso,[1] is a medication used to treat non-small-cell lung carcinomas with specific mutations.[2][3] It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor (see Receptor tyrosine kinases). See also Osimertinib.
| ||||||||||||
This page was last modified 12:08, 10 October 2023.